A process for the preparation of regadenoson

US2016304551A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016304551-A1
Application numberUS-201315102505-A
CountryUS
Kind codeA1
Filing dateDec 10, 2013
Priority dateDec 10, 2013
Publication dateOct 20, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides novel processes for the preparation of regadenoson having the formula (I). In some embodiments, the intermediates for the synthesis of regadenoson are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1 . A process for the preparation of regadenoson of formula I: comprising: (a) contacting a compound of formula II: with a compound of formula IIa: under conditions sufficient to form a compound of formula IV: and (b) converting the compound of formula IV to the compound of formula I; wherein X is a leaving group; R 2 and R 3 are independently-selected hydroxy protecting groups, or R 2 and R 3 are taken together to form a dihydroxy protecting group; and R 4 is selected from the group consisting of hydrogen and a hydroxy protecting group. 2 . The process of claim 1 , wherein the leaving group is halogen. 3 . The process of claim 1 , wherein R 2 and R 3 are taken together to form ethane-1,1-diyl, propane-2,2-diyl, phenylmethanediyl, diphenylmethanediyl, tetramethylene or pentamethylene. 4 . The process of claim 3 , wherein R 2 and R 3 are taken together to form propane-2,2-diyl. 5 . The process of claim 1 , wherein the compound of formula II is: 6 . A process for the preparation of the compound of formula IIb comprising: contacting the compound of formula IIa with acetone, 2,2-dimethoxypropane, 2-methoxypropene, or a combination thereof in the presence of an acid. 7 . The process of claim 6 , wherein the acid is HClO 4 , HCl, DL-10-camphorsulfonic acid or H 2 SO 4 . 8 . The process of claim 7 , wherein the acid is HClO 4 . 9 . The process of claim 1 , wherein formula IV is the compound of IVb:

Assignees

Inventors

Classifications

  • C07H19/167Primary

    with ribosyl as the saccharide radical · CPC title

  • C07H19/16Primary

    Purine radicals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016304551A1 cover?
The present invention provides novel processes for the preparation of regadenoson having the formula (I). In some embodiments, the intermediates for the synthesis of regadenoson are also provided.
Who is the assignee on this patent?
Scinopharm Taiwan Ltd
What technology area does this patent fall under?
Primary CPC classification C07H19/167. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).